March 2022 - Analysis Solutions

In-depth characterizations of OINDPs from R&D to regulatory submission

Post author:admin
Post published:March 30, 2022
Post category:Webinars
Post comments:0 Comments

Next Breath and Gateway Analytical will present their OINDP Webinar Series for Dry powder Inhalers (DPIs), pressurized Metered Dose Inhaler (MDIs), and Nasal drug products which are complex delivery systems…

Gateway Analytical Collaborates with the FDA to Present their Latest Findings on Temperature-mediated Drug Agglomerates

Post author:admin
Post published:March 21, 2022
Post category:News & Event Page
Post comments:0 Comments

PITTSBURGH, March, 11th, 2014 — Gateway Analytical announced today that they have collaborated with researchers from the Division of Pharmaceutical Analysis at the Food and Drug Administration’s Drug Evaluation and Research…

In-depth characterizations of OINDPs from R&D to regulatory submission

Gateway Analytical Collaborates with the FDA to Present their Latest Findings on Temperature-mediated Drug Agglomerates

We're Here to Build Relationships!

Providing specialized support for accelerating your pharmaceutical product's journey to market!

OUR EXPERTISE

INNOVATION / TECH

RESOURCES / NEWS

COMPANY